Company Filing History:
1 out of 8 
1 out of 1 
1 out of 2 Years Active: 2022
Title: The Innovations of Xiaoshan Wang
Introduction
Xiaoshan Wang is a prominent inventor based in Kaifeng, China. He is known for his significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins. His work has the potential to improve treatment options for patients requiring blood-clotting factors.
Latest Patents
Wang holds a patent for a highly glycosylated human blood-clotting factor VIII fusion protein, along with its manufacturing method and applications. This innovative fusion protein includes a human factor VIII, a flexible peptide connector, and a half-life extending portion, which enhances its pharmacokinetics and drug efficacy. The fusion protein demonstrates a similar level of biological activity as recombinant factor VIII while offering an extended in vivo half-life.
Career Highlights
Throughout his career, Xiaoshan Wang has worked with notable companies in the pharmaceutical industry. He has been associated with Ampsource Biopharma Shanghai Inc. and Furen Pharmaceutical Group Co., Ltd. His expertise in protein engineering and drug development has made him a valuable asset in these organizations.
Collaborations
Wang has collaborated with several professionals in his field, including Qiang Li and Wenchen Zhu. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Xiaoshan Wang's innovative work in the field of biotechnology, particularly with his patented fusion protein, showcases his commitment to improving medical treatments. His contributions are paving the way for advancements in therapeutic options for patients in need.